Drugs in development for hepatitis BBUTI, Maria; ESTEBAN, Rafael.Drugs (Basel). 2005, Vol 65, Num 11, pp 1451-1460, issn 0012-6667, 10 p.Article

Hepatitis B vaccination in liver transplant candidatesCASTELLS, Lluis; ESTEBAN, Rafael.European journal of gastroenterology & hepatology. 2001, Vol 13, Num 4, pp 359-361, issn 0954-691XArticle

Hepatitis C virus : Molecular biology and genetic variabilityBRECHOT, C.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 6S-21S, issn 0163-2116, SUPConference Paper

Entecavir, FTC, L-FMAU, LdT and othersBUTI, Maria; ESTEBAN, Rafael.Journal of hepatology. Supplement. 2003, Vol 39, Num 1, pp S139-S142, issn 0169-5185Conference Paper

Hepatitis C : A historical perspectiveSHERLOCK, S.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 3S-5S, issn 0163-2116, SUPConference Paper

Short-term versus sustained response to interferon therapy : Effect on histologyREICHARD, O.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 109S-114S, issn 0163-2116, SUPConference Paper

Managing patients on interferon therapyESTEBAN, R.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 121S-128S, issn 0163-2116, SUPConference Paper

Chronic HCV Infection: Public Health Threat and Emerging Consensus. SymposiumESTEBAN, Rafael; TREPO, Christian.Digestive diseases and sciences. 1996, Vol 41, Num 12, issn 0163-2116, 137 p., SUPConference Proceedings

Magnitude and management of HCV infection in FranceTREPO, C; BAILLY, F.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 22S-26S, issn 0163-2116, SUPConference Paper

Nonhepatic manifestations and combined diseases in HCV infectionHADZIYANNIS, S. J.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 63S-74S, issn 0163-2116, SUPConference Paper

Predictors of response to interferon therapySARACCO, G; RIZZETTO, M.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 115S-120S, issn 0163-2116, SUPConference Paper

Risk factors and prevention of hepatocellular carcinoma in HCV infectionBENVEGNU, L; ALBERTI, A.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 49S-55S, issn 0163-2116, SUPConference Paper

Financial impact of two different ways of evaluating early virological response to peginterferon-α-2b plus ribavirin therapy in treatment-naive patients with chronic hepatitis C virus genotype 1BUTI, Maria; CASADO, Miguel A; FOSBROOK, Leslie et al.PharmacoEconomics (Auckland). 2005, Vol 23, Num 10, pp 1043-1055, issn 1170-7690, 13 p.Article

Hepatitis B virus genome variability and disease progression : the impact of pre-core mutants and HBV genotypesBUTI, Maria; RODRIGUEZ-FRIAS, Francisco; JARDI, Rosendo et al.Journal of clinical virology. 2005, Vol 34, issn 1386-6532, S79-S82, SUP1Conference Paper

Patterns of progression : Unpredictability and risk of decompensated cirrhosisTASSOPOULOS, N. C.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 41S-48S, issn 0163-2116, SUPConference Paper

Two years versus six months of interferon therapy for chronic hepatitis CFARRELL, G. C.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 93S-98S, issn 0163-2116, SUPConference Paper

Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3ZEUZEM, Stefan; DUSHEIKO, Geoffrey M; MANI SUBRAMANIAN, G et al.The New England journal of medicine. 2014, Vol 370, Num 21, pp 1993-2001, issn 0028-4793, 9 p.Article

Randomized Trial of Peginterferon alfa-2b and Ribavirin for 48 or 72 Weeks in Patients with Hepatitis C Virus Genotype 1 and Slow Virologic ResponseBUTI, Maria; LURIE, Yoav; PEDICONE, Lisa D et al.Hepatology (Baltimore, Md.). 2010, Vol 52, Num 4, pp 1201-1207, issn 0270-9139, 7 p.Article

Nosocomial transmission of hepatitis C virus during contrast-enhanced computed tomography scanningQUER, Josep; ESTEBAN, Juan-Ignacio; ESTEBAN, Rafael et al.European journal of gastroenterology & hepatology. 2008, Vol 20, Num 1, pp 73-78, issn 0954-691X, 6 p.Article

Liver transplantation in HIV-HCV coinfected patients : A case-control studyCASTELLS, Lluis; ESCARTIN, Alfredo; ESTEBAN, Rafael et al.Transplantation. 2007, Vol 83, Num 3, pp 354-358, issn 0041-1337, 5 p.Article

Hemodynamic response-guided therapy for prevention of variceal rebleeding : An uncontrolled pilot studyGONZALEZ, Antonio; AUGUSTIN, Salvador; GUARDIA, Jaime et al.Hepatology (Baltimore, Md.). 2006, Vol 44, Num 4, pp 806-812, issn 0270-9139, 7 p.Article

Viral kinetics in genotype 1 chronic hepatitis C patients during therapy with 2 different doses of peginterferon alfa-2b plus ribavirinBUTI, Maria; SANCHEZ-AVILA, Francisco; LURIE, Yoav et al.Hepatology (Baltimore, Md.). 2002, Vol 35, Num 4, pp 930-936, issn 0270-9139Article

Role of hepatitis B, C, and D viruses in dual and triple infection: influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interferenceJARDI, Rosendo; RODRIGUEZ, Francisco; BUTI, Maria et al.Hepatology (Baltimore, Md.). 2001, Vol 34, Num 2, pp 404-410, issn 0270-9139Article

Usefulness of magnetic resonance spectroscopy for diagnosis of hepatic encephalopathy in a patient with relapsing confusional syndromeCORDOBA, Juan; HINOJOSA, Carmen; SAMPEDRO, Francesc et al.Digestive diseases and sciences. 2001, Vol 46, Num 11, pp 2451-2455, issn 0163-2116Article

Duration of HCV infection as a predictor of nonresponse to interferonCRAXI, A; DI MARCO, V; GAMMA, C et al.Digestive diseases and sciences. 1996, Vol 41, Num 12, pp 86S-92S, issn 0163-2116, SUPConference Paper